相关实验视频

Updated: Jun 7, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

在性结肠炎中对肠道免疫和生物治疗反应中的细胞衰老的综合评估

Baojia Yao¹, Yawei Zhang¹, Qiang Wu¹

¹Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.

Scientific reports

|November 15, 2024

概括

细胞衰老与性结肠炎 (UC) 中的炎症有关,涉及六个关键基因. 这些基因与免疫细胞相关,并预测UC患者在生物治疗中的疾病缓解.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

性结肠炎 (UC) 涉及慢性肠道炎症和免疫失调.
细胞衰老与慢性炎症有关,但其在UC中的作用尚未完全理解.

研究的目的:

在UC中识别与细胞衰老相关的基因.
探索这些基因,免疫透和UC患者疾病缓解之间的关系.
根据与衰老相关的基因开发UC的诊断模型.

主要方法:

对UC数据集的生物信息分析以选与细胞衰老相关的差异表达基因 (DEGs).
免疫透分析,权重基因联合表达网络分析 (WGCNA),基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径分析.
使用单细胞和临床缓解数据构建临床诊断名录和验证.

主要成果:

确定了与UC细胞衰老相关的六个关键的DEG (TWIST1,IGFBP5,MME,IFNG,ME1,FOS).
这些基因与免疫细胞和与炎症相关的途径有很强的相关性.
基于这些基因的诺米图表显示了UC的良好诊断能力,并预测了接受生物治疗的患者的疾病缓解.

结论:

细胞衰老在性结肠炎的发病过程中起着重要作用.
已识别的与衰老相关的基因为UC诊断和预后提供了潜在的生物标志物.
这些发现为管理UC和减轻肠道衰老提供了新的治疗点.

关键词:

生物制剂生物制剂生物制剂细胞衰老细胞衰老在GEO数据集中,GEO数据集包括:免疫系统的免疫系统.炎症性肠病是一种炎症性肠病.性结肠炎是一种

更多相关视频

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...